These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37068956)

  • 1. Teaching NeuroImage: Low-Frequency Photoparoxysmal Response in a Patient With Neuronal Ceroid Lipofuscinosis Type 2.
    Mirchi A; Myers KA
    Neurology; 2023 Jul; 101(4):e459-e460. PubMed ID: 37068956
    [No Abstract]   [Full Text] [Related]  

  • 2. Unique Characteristics of the Photoparoxysmal Response in Patients With Neuronal Ceroid Lipofuscinosis Type 2: Can EEG Be a Biomarker?
    Albert DV; Yin H; De Los Reyes EC; Vidaurre J
    J Child Neurol; 2016 Nov; 31(13):1475-1482. PubMed ID: 27445018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoparoxysmal response in late infantile neuronal ceroid-lipofuscinosis.
    Naqvi SZ; Beach RL; Armao DM; Greenwood RS
    Pediatr Neurol; 1998 Nov; 19(5):395-8. PubMed ID: 9880149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autism, Epilepsy, and Neuroregression: Photosensitivity on Electroencephalography Solved the Riddle.
    Madaan P; Jauhari P; Luhar ZM; Chakrabarty B; Gulati S
    Clin EEG Neurosci; 2020 Nov; 51(6):399-402. PubMed ID: 31903771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photosensitivity is an early marker of neuronal ceroid lipofuscinosis type 2 disease.
    Specchio N; Bellusci M; Pietrafusa N; Trivisano M; de Palma L; Vigevano F
    Epilepsia; 2017 Aug; 58(8):1380-1388. PubMed ID: 28632327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, electrophysiological, imaging, and ultrastructural description in 68 patients with neuronal ceroid lipofuscinoses and its subtypes.
    Jadav RH; Sinha S; Yasha TC; Aravinda H; Gayathri N; Rao S; Bindu PS; Satishchandra P
    Pediatr Neurol; 2014 Jan; 50(1):85-95. PubMed ID: 24120650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.
    Yu F; Liu XM; Chen YH; Zhang SQ; Wang K
    Neurol Sci; 2015 Oct; 36(10):1917-9. PubMed ID: 26032578
    [No Abstract]   [Full Text] [Related]  

  • 9. The neuronal ceroid-lipofuscinoses.
    Goebel HH
    J Child Neurol; 1995 Nov; 10(6):424-37. PubMed ID: 8576551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel neuroimaging finding in palmitoyl protein thioesterase-1-related neuronal ceroid lipofuscinosis.
    Kamate M; Hattiholi V
    Pediatr Neurol; 2012 May; 46(5):325-8. PubMed ID: 22520356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Electroencephalogram (EEG) and Magnetic Resonance Imaging (MRI) Findings in Early Recognition and Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 Disease.
    Ho ML; Wirrell EC; Petropoulou K; Sakonju A; Chu D; Seratti G; Palasis S
    J Child Neurol; 2022 Dec; 37(12-14):984-991. PubMed ID: 36184928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset childhood neuronal ceroid lipofuscinosis: Early clinical and electroencephalographic markers.
    Beltrán L; Valenzuela GR; Loos M; Vargas R; Lizama R; Spinsanti P; Caraballo R
    Epilepsy Res; 2018 Aug; 144():49-52. PubMed ID: 29778029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.
    Levin SW; Baker EH; Zein WM; Zhang Z; Quezado ZM; Miao N; Gropman A; Griffin KJ; Bianconi S; Chandra G; Khan OI; Caruso RC; Liu A; Mukherjee AB
    Lancet Neurol; 2014 Aug; 13(8):777-87. PubMed ID: 24997880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalography in autosomal dominant adult neuronal ceroid lipofuscinosis.
    Nijssen PC; Brekelmans GJ; Roos RA
    Clin Neurophysiol; 2009 Oct; 120(10):1782-6. PubMed ID: 19699676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric-onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis.
    Dozières-Puyravel B; Nasser H; Elmaleh-Bergès M; Lopez Hernandez E; Gelot A; Ilea A; Delanoë C; Puech JP; Caillaud C; Pichard S; Auvin S
    Dev Med Child Neurol; 2020 Apr; 62(4):528-530. PubMed ID: 31489614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report.
    Hosseini Bereshneh A; Garshasbi M
    J Med Case Rep; 2018 Sep; 12(1):281. PubMed ID: 30249282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase isoenzymes in cerebrospinal fluid and plasma from patients with neuronal ceroid-lipofuscinoses.
    Marklund SL; Heiskala H; Westermarck T; Santavuori P
    Clin Sci (Lond); 1986 Jul; 71(1):57-60. PubMed ID: 3709075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrophysiologic variants in late infantile neuronal-ceroid lipofuscinosis].
    Jović N
    Srp Arh Celok Lek; 1999; 127(11-12):407-11. PubMed ID: 10686824
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel Mutations in CLN5 of Chinese Patients With Neuronal Ceroid Lipofuscinosis.
    Ge L; Li HY; Hai Y; Min L; Xing L; Min J; Shu HX; Mei OY; Hua L
    J Child Neurol; 2018 Nov; 33(13):837-850. PubMed ID: 30264640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.